Skip to main content
. Author manuscript; available in PMC: 2026 Aug 27.
Published in final edited form as: Clin Microbiol Infect. 2013 Aug 30;20(5):441–446. doi: 10.1111/1469-0691.12335

TABLE 2.

Proportion of patients receiving each tuberculosis drug (n = 213)

Drug Received before starting salvage therapy Received as a part of salvage therapy

Moxifloxacin 9.4% (20) 50.7% (108)
Capreomycin 51.2% (109) 33.8% (72)
Amoxicillin-clavulanate 56.3% (120) 23.4% (50)
Kanamycin 53.5% (114) 20.7% (44)
Clarithromycin 5.6% (12) 20.7% (44)
PAS 89.7% (191) 9.4% (20)
Streptomycin 15.0% (32) 9.4% (20)
Pyrazinamide 43.2% (92) 8.9% (19)
Ethambutol 32.9% (70) 7.5% (16)
Clofazamine 51.6% (110) 6.6% (14)
Rifabutin 1.9% (4) 5.6% (12)
Ethionamide/prothionamide 83.6% (178) 4.7% (10)
Isoniazid 5.2% (11) 3.8% (8)
Cycloserine 96.2% (205) 2.8% (6)
Ciprofloxacin/ofloxacin 90.6% (193) 2.8% (6)
Rifampicin 5.2% (11) 2.8% (6)
Levofloxacin 4.2% (9) 0.5% (1)

PAS, para-aminosalicylic acid.